Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
Japan Active Pharmaceutical Ingredient Market Assessment, By Synthesis [Biotech, Synthetic], By Potency [Traditional API, HPAPI], By Manufacturer [Captive APIs, Merchant APIs], By Type [Generic APIs, Innovative APIs], By Drug [Prescription Drugs, Over-the-counter Drugs], By Usage [Clinical, Research], By Application [Cardiovascular diseases, Oncology, Neurology, Orthopedic, Diabetes, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, Others], By Region, Opportunities and Forecast, FY2017-FY2031F
... [Clinical, Research], By Application [Cardiovascular diseases, Oncology, Neurology, Orthopedic, Diabetes, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, Others], By Region, Opportunities and Forecast, FY2017-FY2031F Japan Active pharmaceutical ingredient market size was valued at USD 20.11 billion in FY2023, ... Read More
-
Gene Therapy Market Assessment, By Type [Gene Silencing, Cell Replacement, Gene Augmentation, Others], By Vector [Non-Viral Vectors, Viral Vectors], By Gene Delivery Method [Ex vivo and In vivo], By Application [Oncological Diseases, Neuromuscular Diseases, Cardiovascular Diseases, Infectious Diseases, Genetic Diseases, Haematological Diseases, Others], By Route of Administration [Intravenous, Oral, Intramuscular, Others], By End-users [Hospitals, Cancer and Research Institutes, Clinics, Others], By Region, Opportunities and Forecast, 2017-2031F
... Diseases, Infectious Diseases, Genetic Diseases, Haematological Diseases, Others], By Route of Administration [Intravenous, Oral, Intramuscular, Others], By End-users [Hospitals, Cancer and Research Institutes, Clinics, Others], By Region, Opportunities and Forecast, 2017-2031F Global gene therapy market ... Read More
-
Cancer biologics Global Market Report 2024
... Cancer; Colorectal Cancer; Gastric Cancers3) By Distribution Channel: Hospitals; ClinicsCovering: AbbVie Inc.; F. Hoffmann-La Roche AG; GlaxoSmithKline plc; Eli Lilly and Company; AmgenInc. Cancer biologics Global Market Report 2024 from The Business Research Company provides ... Read More
-
Breast Cancer Monoclonal Antibodies Global Market Report 2024
... Covering: Amgen Inc.; Mylan N.V.; Merck & Co. Inc.; Novartis AG; GlaxoSmithKline plc. Breast Cancer Monoclonal Antibodies Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical ... Read More
-
Global POC Analyzers for Cancer Market Growth 2024-2030
... at a CAGR of % from 2024 to 2030. LP Information, Inc. (LPI) ' newest research report, the “POC Analyzers for Cancer Industry Forecast” looks at past sales and reviews total world POC Analyzers for ... Read More
-
Global Cancer Biologics Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Oncology Biosimilars Global Market Report 2024
... Cancer 3) By Distribution Type: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy Covering: Biocon Biologics Limited; Celltrion Inc.; Dr. Reddy's Laboratories Ltd.; Intas Pharmaceuticals Ltd.; STADA Arzneimittel AG Oncology Biosimilars Global Market Report 2024 from The ... Read More
-
Highly Potent API Market - A Global and Regional Analysis: Focus on Type, Type of Synthesis, Therapeutic Area, Type of Manufacturing, End User, and Country - Analysis and Forecast, 2023-2033
... Market The global highly potent API market is projected to reach $84.20 billion by 2033 from $27.44 billion in 2023, growing at a CAGR of 11.86% during the forecast period 2023-2033. The key factors driving ... Read More
-
Peripheral Interventions Market Forecasts to 2030 – Global Analysis By Product (Catheters, Sheath, Guide Wires, Atherectomy Devices, Embolic Devices, Stents, Inferior Vena Cava (IVC) Thrombectomy Devices, Plaque Modification Device, Hemodynamic Flow Alteration Devices and Other Products), Procedures (Oncology Procedures, Gastric, Neurology, Skin Procedures, Uteral, Renal, Hepatic and Other Procedures), Application, End User and By Geography
... Products), Procedures (Oncology Procedures, Gastric, Neurology, Skin Procedures, Uteral, Renal, Hepatic and Other Procedures), Application, End User and By Geography According to Stratistics MRC, the Global Peripheral Interventions Market is accounted for $8,952.2 million in ... Read More
-
Kaposi Sarcoma Market Forecasts to 2030 – Global Analysis By Type (Classic Kaposi Sarcoma, Endemic Kaposi Sarcoma, Epidemic Kaposi Sarcoma, Immunosuppression-Associated Kaposi Sarcoma, Latrogenic Kaposi Sarcoma, Disseminated Kaposi Sarcoma and Other Types), Diagnostic Method, Treatment Modality, End User and By Geography
... Modality, End User and By Geography According to Stratistics MRC, the Global Kaposi Sarcoma Market is accounted for $108.69 million in 2023 and is expected to reach $150.92 million by 2030 growing at a CAGR ... Read More
-
Lung Cancer Diagnostics Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Companies Analysis
... according to Renub Research. In modern-day healthcare, lung cancer diagnostics are pivotal in early detection and personalized treatment. Advanced imaging strategies like CT scans and MRI permit particular identification of tumors and metastases, assisting in ... Read More
-
Genomics In Cancer Care Global Market Report 2024
... By End-user: Hospitals; Government Institutes; Research FacilitiesCovering: Illumina Inc.; Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; PerkinElmer Inc.; QIAGEN N.V. Genomics In Cancer Care Global Market Report 2024 from The Business Research Company provides strategists, ... Read More
-
Oncology Precision Medicine Market
... Neck Squamous Cell Cancer, Lung Cancer, Skin Cancer and Others), Route of Administration (Oral, Intravenous and Others), Type of Molecule (Small Molecules and Biologics), Drug Class (Kinase Inhibitors, Enzyme Inhibitors, Immune Checkpoint Inhibitors and Others), ... Read More
-
Advanced Renal Cell Carcinoma- Pipeline Insight, 2024
... the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this ... Read More
-
Non-Small-Cell Lung cancer (NSCLC) - Pipeline Insight, 2024
... It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products ... Read More
-
HER2 Negative Breast Cancer- Pipeline Insight, 2024
... the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this ... Read More
-
Cancer Biomarker Global Market Report 2024
... Cancer; Thyroid Cancer; Kidney Cancer4) By Application: Diagnostics; Research And Development; Prognostics; Risk AssessmentCovering: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; QIAGEN NV; Illumina Inc.; Bio-Rad Laboratories Inc. Cancer Biomarker Global Market Report 2024 ... Read More
-
Prevention and Treatment of Prostate Cancer: Technologies and Global Markets
... recommendations for the success of market participants. The scope of the study is global. This report estimates market data for 2022 (the base year) and provides forecasts for 2023 through 2028. Figures for 2023 are ... Read More
-
Acute Myeloid Leukemia Market - By Disease (Myeloblastic, Myelomonocytic, Promyelocytic), Treatment (Chemotherapy, Targeted Therapy), Route of Administration (Oral, Parenteral), End-user (Hospital, Clinic, Specialty Center) & Forecast 2024 - 2032
... will grow at 10.7% CAGR from 2024 to 2032, propelled by regulatory approvals for novel drugs and therapies for the disease treatment. Rapid advancements in treatment options and the ongoing R&D efforts are providing patients ... Read More
-
PEGylated Proteins Market Report by Product (Consumables, Services), Protein Type (Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VII, and Others), Application (Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorders, and Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2024-2032
... End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2024-2032 The global PEGylated proteins market size reached US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the market ... Read More
-
Medical Cannabis Market Report by Species (Indica, Sativa, Hybrid), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC), and Others), Application (Cancer, Arthritis, Migraine, Epilepsy, and Others), End-Use (Pharmaceutical Industry, Research and Development Centres, and Others), Route of Administration (Oral Solutions and Capsules, Vaporizers, Topicals, and Others), and Region 2024-2032
... (Oral Solutions and Capsules, Vaporizers, Topicals, and Others), and Region 2024-2032 The global medical cannabis market size reached US$ 34.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 66.7 Billion ... Read More
-
US Generic Drug Market Report by Segment (Unbranded, Branded), Therapy Area (CNS, Cardiovascular, Dermatology, Genitourinary/Hormonal, Respiratory, Rheumatology, Diabetes, Oncology, and Others), Drug Delivery (Oral, Injectables, Dermal/Topical, Inhalers), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) 2024-2032
... US generic drug market size reached US$ 90.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 124.3 Billion by 2032, exhibiting a growth rate (CAGR) of 3.5% during 2024-2032. The ... Read More
-
Theranostics Market by Product (Diagnostic imaging (PET, CT, MRI), Radiopharmaceuticals (Lu-177, Sm-153, Ra-223, I-131), Biomarker screening, Software), Application (Prostate Cancer, Bone metastasis), & Stakeholder Expectations - Global Forecast to 2028
... projected to reach USD 4.3 billion by 2028 from USD 2.1 billion in 2023, at a CAGR of 15.5% from 2023 to 2028. Factors such as rising baby boomer population and advances in research and ... Read More
-
Colonoscopy Devices Market Report by Product Type (Colonoscope, Visualization Systems, and Others), Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn’s Disease, and Others), End User (Hospitals, Ambulatory Surgery Center, and Others), and Region 2024-2032
... global colonoscopy devices market size reached US$ 1.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4.64% during 2024-2032. The ... Read More
-
Non-muscle Invasive Bladder Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middl
... and Africa) The global non-muscle invasive bladder cancer therapeutics market reached a valuation of US$ 2.8 billion in 2024. The market is forecasted to progress to reach US$ 9.2 billion by the end of 2031. ... Read More
Research Assistance
